This site uses cookies to store information on your computer. Learn more x

Share buy-back program 2016

DSM finalizes repurchase of shares to cover existing option plans and stock dividend

Royal DSM, a global science-based company active in health, nutrition and materials, has repurchased 83,073 of its own shares in the period from 15 July 2016 up to and including 21 July 2016 at an average price of €56.75. This is in accordance with the repurchase, covering existing option plans and stock dividends, announced on 22 February 2016 and as amended on 10 May 2016. The consideration of this repurchase was €4.7 million. This repurchase concludes the program to repurchase 3,500,000 shares for a total consideration of €176.8 million.

Statement pursuant to art. 5:25a of the Dutch Financial Supervision Act

DSM also announces that The Netherlands is its "Home Member State", as required by article 5:25a (2) of the Dutch Financial Supervision Act. This article obliges all listed companies to publicly announce which country is their "home member state" (as referred to in article 5:25a(1) sub c of the Dutch Financial Supervision Act) for purposes of regulation of their disclosure obligations under the EU Transparency Directive. Pursuant to section 5:25a of the Dutch Financial Supervision Act Royal DSM has notified the Autoriteit Financiële Markten (AFM).